Ben-Tzvi Avraham (CIK 1944721) reported 2 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-01-22). Recent activity: Buy INDP (25,000 shares), Sell TTNP (3,313 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-22 | Indaptus Therapeutics, Inc. (INDP) | Director | Buy | 25,000 | $0 |
| 2025-10-08 | TITAN PHARMACEUTICALS INC (TTNP) | Director | Sell | 3,313 | $0 |
Source: SEC Form 4 filings · as of 2026-01-22